Search

Search Constraints

You searched for: Author/Creator Daina, Erica

Search Results

1. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. (March 2016)

2. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. (March 2016)

3. FC 036IPTACOPAN (LNP023): A NOVEL ORAL COMPLEMENT ALTERNATIVE PATHWAY FACTOR B INHIBITOR SAFELY AND EFFECTIVELY STABILISES EGFR IN C3 GLOMERULOPATHY. (29th May 2021)

4. FP050URINARY PEPTIDOME ANALYSIS ALLOWS NON-INVASIVE DIAGNOSIS OF THE RCAD SYNDROME. (18th May 2018)

5. FP050URINARY PEPTIDOME ANALYSIS ALLOWS NON-INVASIVE DIAGNOSIS OF THE RCAD SYNDROME. (18th May 2018)

8. MO126CLINICAL AND BIOMARKER CHARACTERISTICS OF PATIENTS WITH C3G OR IC-MPGN ENROLLED IN TWO PHASE II STUDIES INVESTIGATING THE FACTOR D INHIBITOR DANICOPAN*. (29th May 2021)

9. Unravelling the pathophysiology of C3G/IC-MPGN and how to predict disease progression and orient therapies. (September 2017)